0% found this document useful (0 votes)
43 views18 pages

Metabolism of Drugs

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1/ 18

Metabolism of Drugs

PRESENTE MODERATO
R
Dr. R. Janarthanan
R Dr. Jyoti Patil
1st Year MBBS ASSISTANT PROFESSOR
Dept. of Pharmacology Dept. of Pharmacology
BLDE BLDE
INTRODUCTIO
N
• Termination of Drug Action - Biotransformation, Excretion and Tissue Reabsorption

• TERMS : Biotransformation, Detoxification, Drug Metabolism

• DEFINITION : Enzyme - catalyzed biochemical transformation of drugs within the


living organisms.

• The biotransformation reaction of any drug may have three different consequences
⚬ Active Drug to Inactive Drug ( Phenobarbitone to Hydroxyphenobarbitone)
⚬ Inactive Drug to Active Drug ( PRO - Drugs : L-DOPA to Dopamine)
⚬ Active Drug to Equally Active drug (Diazepam to Oxazepam)
FIRST PASS
METABOLISM
• All drugs taken orally, first of all, pass through GIT wall and then through portal system,

before reaching the systemic circulation.


• First-Pass Metabolism - drug metabolism occurring before the drug enters the systemic

circulation.
• Decreased bioavailability of the drug diminished therapeutic response, because a

significant amount of the drug is inactivated before reaching the systemic circulation.
• The first-pass effect may be bypassed if the drug is administered parenterally or

sublingually
PHASES OF DRUG
METABOLISM
Phase I Reactions

⚬ Degenerative reactions
⚬ Smaller Polar/Non-polar metabolites by introduction of new group (-OH, -NH2)
⚬ Oxidation, Reduction, Hydrolysis.
⚬ Metabolite formed may - Active/Inactive

Phase II Reactions

⚬ Synthetic/ Conjugation reactions


⚬ Catalyzed by Microsomal, Mitochondrial or Cytoplasmic enzymes
⚬ Metabolite formed is mostly Inactive
⚬ Drug which acquire reactive groups ( NH2, COOH or OH ) in Phase I reaction undergoes
Phase II reaction
DRUG METABOLIZING
ENZYMES
1. Microsomal Enzymes:

⚬ Location: Smooth endoplasmic reticulum of liver, also in intestines, lungs, kidneys.

⚬ Key Enzymes: Cytochrome P-450 (CYPs), Glucuronyl transferase.

⚬ Functions:
■ Phase I Reactions: Oxidation, reduction, hydrolysis.
■ Phase II Reactions: Glucuronyl conjugations.

⚬ CYP3A, CYP2D, CYP2C.


■ CYP3A4/5: Metabolize approx. 50% of drugs
■ CYP2D6: Metabolizes 25-30% of drugs
■ CYP2C8/9: Metabolizes 10% of drugs
DRUG METABOLIZING ENZYMES
(CONTD....)
2. Non-Microsomal Enzymes:

⚬ Location: Cytoplasm, mitochondria, plasma.

⚬ Key Enzymes: Monoamine oxidase, esterases, transferases.

⚬ Functions: Phase II reactions (except glucuronidation), certain oxidations, reductions,


hydrolytic reactions.

⚬ Characteristics: Non-inducible, can be inhibited, show genetic variation.


ENZYMATIC
BIOTRANSFORMATIO
N
PHASE I
REACTIONS: OXIDATIONS
• Microsomal Oxidations (CYP-dependent):

⚬ Aromatic Hydroxylations: Phenobarbitone to p-hydroxyphenobarbitone.


⚬ Aliphatic Hydroxylations: Pentobarbitone to hydroxypentobarbitone.
⚬ N-, O-, and S-Dealkylation: Morphine to normorphine.
⚬ N- and S-Oxidation: Trimethylamine to trimethylamine N-oxide.
⚬ Deamination: Amphetamine to phenylacetone derivative.
⚬ Desulfurisation: Parathion to paraoxon.

• Non-microsomal Oxidations:

⚬ Mitochondrial Oxidations: Epinephrine to vinyl-mandelic acid.


⚬ Cytoplasmic Oxidation: Alcohol to acetic acid.
⚬ Plasma Oxidation: Histamine to imidazole acetic acid.
PHASE I REACTIONS:
REDUCTIONS
• Microsomal Reductions:

⚬ Nitro Reduction: e.g., Chloramphenicol to arylamine metabolite.


⚬ Azo Reduction: e.g., Prontosil to sulfanilamide.
⚬ Keto Reduction: e.g., Cortisone to hydroxycortisone.

• Non-microsomal Reductions:

⚬ Example: Chloral hydrate to trichloroethanol.


PHASE I REACTIONS:
HYDROLYSIS

• Microsomal Hydrolysis:

⚬ Rare Example: Pethidine to pethidinic acid.

• Non-microsomal Hydrolysis:

⚬ Mainly for esters and amides Example: Procaine to PABA


PHASE II REACTIONS:
CONJUGATIONS
• Microsomal Conjugations:

⚬ Glucuronide Conjugation: e.g., Morphine glucuronide.

• Non-microsomal Conjugations:

⚬ N-Acetylation: e.g., Isoniazid.


⚬ Sulfate Conjugation: e.g., Paracetamol.
⚬ Amino Acid Conjugation: e.g., Aspirin.
⚬ Methylation: e.g., Dopamine.
⚬ Glutathione Conjugation: e.g., Ethacrynic acid.
⚬ Ribosides: e.g., Antimetabolites in cancer.
NON-ENZYMATIC
BIOTRANSFORMATIO
N
HOFMANN
ELIMINATION
• Definition: Non-enzymatic drug biotransformation.

• Mechanism: Spontaneous molecular rearrangement, no enzyme needed.

• Atracurium: used as Muscle. relaxant in surgeries Undergoes Hofmann elimination.


• Products: Laudanosine and quaternary acrylate (inactive).

• Clinical Relevance:
⚬ Predictable Metabolism: Independent of liver/kidney function.

⚬ Rapid Clearance: Ensures consistent duration of action.

⚬ Safe for Organ Dysfunction: Ideal for patients with liver/kidney issues.
ENZYME
INDUCTION

• Clinical Consequences:

⚬ Decreased drug effect if metabolite inactive.


⚬ Increased drug activity if metabolite active.

• Examples:
⚬ Oral contraceptives with phenytoin.
⚬ Warfarin with barbiturates.
⚬ Phenytoin and osteomalacia.
ENZYME
INHIBITION

• Potential Adverse Effects:

⚬ Increased drug levels and toxicity.


⚬ Enhanced effects of co-administered drugs.

• Examples:
⚬ Theophylline with chloramphenicol.
⚬ Dicumarol with cimetidine.
FACTORS AFFECTING DRUG
METABOLISM

• Age: Neonates and elderly have altered metabolism.


• Sex: Minimal impact in humans but notable in animals.
• Species: Species-dependent variations, e.g., rabbits with atropine.
• Race: Some racial differences, e.g., alcohol metabolism in Chinese.
• Genetic Variation: Genetic differences impact drug metabolism rates.
• Nutrition and Diet: Protein-rich diets enhance metabolism.
• Disease: Hepatic diseases impair drug metabolism.
• Drug-Drug Interactions: Enzyme induction or inhibition affects drug metabolism.
Thank You

You might also like